- Home
- / Peter MacCallum Cancer Centre
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Peter MacCallum Cancer Centre financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$825.9 M
FY, 2021
CreditSafe Score
?
Score changed on Jun 11, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| AUD | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|
| Revenue | 685.1M | 748.1M | 825.9M |
| Cost of goods sold | 125.6M | 140.4M | 159.9M |
| Gross profit | 559.5M | 607.7M | 666.0M |
| Gross profit margin, % | 81.7% | 81.2% | 80.6% |
| General and administrative expense | 321.1M | 402.4M | 443.7M |
| Operating expense total | 471.2M | 507.1M | 558.3M |
| Depreciation and amortization | 61.4M | 55.7M | 61.3M |
| EBIT | 3.8M | 32.7M | 31.6M |
| EBIT margin, % | 0.6% | 4.4% | 3.8% |
| Pre tax profit | (2.2M) | 26.0M | 51.0M |
| Income tax expense | (115.0K) | 118.0K | (673.0K) |
| Net Income | (2.1M) | 25.9M | 51.6M |